Current Challenges in Treating Unresectable Hepatocellular Carcinoma by Jean-François Dufour

Get full text

Should we undertake surveillance for HCC in patients with MAFLD? by Blanca Norero, Jean-François Dufour

Get full text

Surveillance for Hepatocellular Carcinoma in Patients with NASH by Philippe Kolly, Jean-François Dufour

Get full text

Nicotinamide and NAFLD: Is There Nothing New Under the Sun? by Maria Guarino, Jean-François Dufour

Get full text

Intricate interpretation of etiology-specific outcome comparison in patients with hepatocellular carcinoma by Hwi Young Kim, Jean-François Dufour

Get full text

Effects of Home Care on patients with hepatocellular carcinoma treated with sorafenib by Monika Moser, Iuliana‐Pompilia Radu, Jean‐François Dufour

Get full text

Spatial lipidomics reveals zone-specific hepatic lipid alteration and remodeling in metabolic dysfunction-associated steatohepatitis by Patcharamon Seubnooch, Matteo Montani, Jean-Francois Dufour, Mojgan Masoodi

Get full text

Hepatitis C: a changing epidemic by Gilles Wandeler, Jean-François Dufour, Philip Bruggmann, Andri Rauch

Get full text

Potentials and pitfalls of clinical peptidomics and metabolomics by Alexander Benedikt Leichtle, Jean-François Dufour, Georg Martin Fiedler

Get full text

Macro-AST in an asymptomatic young patient by Haithem Chtioui, Olivier Mauerhofer, Beatrice Günther, Jean-François Dufour

Get full text

Association of modifiable metabolic risk factors and lifestyle with all-cause mortality in patients with hepatocellular carcinoma by Hwi Young Kim, Hye Ah Lee, Pompilia Radu, Jean-François Dufour

Get full text

Estimating the prevalence of adults at risk for advanced hepatic fibrosis using FIB-4 in a Swiss tertiary care hospital. by Petra Strajhar, Annalisa Berzigotti, Henning Nilius, Michael Nagler, Jean-François Dufour

Get full text

Modelling the microelimination of chronic hepatitis C in the canton of Bern, Switzerland: Reaching the Swiss Hepatitis Strategy goals despite the impact of the COVID 19 pandemic. by Olivier Schorr, Sarah Blach, Christine Thurnheer, Christian Ruis, Jean-Francois Dufour

Get full text

Antitumour necrosis factor-α agents and development of new-onset cirrhosis or non-alcoholic fatty liver disease: a retrospective cohort by Susan Hutfless, Ruben Hernaez, Kuo-Tung Tang, Jean-François Dufour, Po-Hung Chen

Get full text

Transcriptomics-driven metabolic pathway analysis reveals similar alterations in lipid metabolism in mouse MASH model and human by Sofia Tsouka, Pavitra Kumar, Patcharamon Seubnooch, Katrin Freiburghaus, Marie St-Pierre, Jean-François Dufour, Mojgan Masoodi

Get full text

Hepatic manifestations of drug reaction with eosinophilia and systemic symptoms syndrome by Maria Gabriela Delgado, Stefania Casu, Matteo Montani, Felix Brunner, Nasser Semmo, Annalisa Berzigotti, Jean François Dufour

Get full text

Characterisation of hepatic lipid signature distributed across the liver zonation using mass spectrometry imaging by Patcharamon Seubnooch, Matteo Montani, Sofia Tsouka, Emmanuelle Claude, Umara Rafiqi, Aurel Perren, Jean-Francois Dufour, Mojgan Masoodi

Get full text

Factors affecting screening for hepatocellular carcinoma by Farah Al Hasani, Marina Knoepfli, Armin Gemperli, Attila Kollar, Vanessa Banz, Joachim Kettenbach, Peter Jüni, Jean-François Dufour

Get full text

The global epidemiology of nonalcoholic steatohepatitis (NASH) and associated risk factors–A targeted literature review by Jean-François Dufour, Roger Scherer, Maria-Magdalena Balp, Sarah Jane McKenna, Nico Janssens, Patricia Lopez, Marcos Pedrosa

Get full text

Treatment allocation in hepatocellular carcinoma: Assessment of the BCLC algorithm by Mandy Richani, Philippe Kolly, Marina Knoepfli, Evelyn Herrmann, Martin Zweifel, Hendrik von Tengg-Kobligk, Daniel Candinas, Jean-François Dufour

Get full text